The announcement of a public offering and private placement typically leads to a dilution of existing shares, which can result in a decrease in share price as the market adjusts to the increased share supply. Given that Accelerate Diagnostics has announced a $15 million offering, this is likely to have a negative impact on the stock price in the short term.